FSI Pivots to Food Sector Amid Ag Market Woes, Eyes Major 2026 Growth

TABER, ALBERTA – January 23, 2026 – Flexible Solutions International (NYSE-AMERICAN: FSI) announced preliminary revenue figures for its fourth quarter and full fiscal year 2025, revealing modest top-line growth that belies a year of significant strategic transformation and investment. The environmental technology company is navigating headwinds in its traditional agricultural markets by making a substantial and calculated pivot toward the high-growth food and nutrition sector, a move it expects will fuel significant growth in 2026.

The company reported fourth-quarter revenue of approximately $9.10 million, a 3% increase from the $8.84 million recorded in the same period of 2024. Full-year revenue for 2025 saw a slight 1% rise to $38.50 million, up from $38.23 million the previous year. While the figures indicate stability, they mask the underlying challenges and strategic repositioning that defined the fiscal year.

CEO Dan O’Brien characterized the period as one of major change. “The 2025 year was one of transition as our Panama factory was built and our Illinois factory was retooled for our new contracts,” he stated in the press release. This period of heavy investment and operational overhaul occurred as the company faced external market pressures. “Agriculture was difficult all year in all geographies. This obscured the excellent forward progress in food grade products.”

The Cost of Transition and Long-Term Investment

Flexible Solutions’ 2025 was marked by significant capital projects designed to reshape its operational footprint and enhance its production capabilities for future growth. The company undertook the construction of a new manufacturing facility in Panama, a strategic move intended to serve its international customer base more efficiently. This plant, located just 30 minutes from a major port, is designed to duplicate the production of nearly all of FSI’s agriculture and polymer products. Its key advantages include the ability to source raw materials without incurring U.S. tariffs for international sales and drastically improved shipping logistics, avoiding costly transit across the United States. The company notably funded this expansion entirely through cash flow and retained earnings, avoiding new debt or equity financing.

Simultaneously, the company’s factory in Peru, Illinois, underwent significant retooling. This project was specifically aimed at preparing the facility for large-scale production of food-grade products, a new and promising venture for the company. The costs associated with both the Panama plant construction and the Illinois retooling were expensed as they occurred, which, according to company statements, negatively impacted profits in the latter half of 2025. This proactive investment in future capacity helps explain the muted bottom-line expectations for the year, even as the groundwork was laid for a substantial revenue ramp-up.

As part of this strategic realignment, FSI also divested its Mendota plant in October 2025, signaling a consolidation of its manufacturing footprint to focus on its most strategic assets. The company has guided that with these one-time transition costs largely in the past, it expects profits to normalize and then increase significantly in early 2026 as revenue from its new ventures begins to accelerate.

A Major Bet on the Food & Nutrition Market

The most significant element of FSI’s strategic shift is its aggressive entry into the food and nutrition supplement manufacturing market. This move leverages its expertise in biodegradable thermal polyaspartate (TPA) biopolymers, now applied to a sector experiencing explosive growth. The company laid the groundwork for this pivot in 2022 by obtaining FDA food-grade approval for its Peru, Illinois facility.

The scale of this new venture became clear in January 2025, when FSI announced a landmark five-year manufacturing agreement with an unnamed U.S. company for food-grade products. The contract carries a projected annual revenue of between $15 million and $30 million—a figure that could nearly double the company's entire 2025 revenue at its upper range. This strategic move aligns perfectly with powerful market trends. The global nutraceuticals market, valued at nearly $489 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 9.2% through 2032, driven by consumer demand for health, wellness, and natural ingredients.

Furthermore, the food biopolymers market itself is expanding rapidly, with a forecasted CAGR of 13.9% through 2030, reflecting a shift toward sustainable and natural food additives. FSI's pivot appears to be timed to capitalize on this demand. Early signs indicate the strategy is already bearing fruit. Production for a second food contract commenced late in the third quarter of 2025, with initial revenue of over $1 million already invoiced in the fourth quarter, confirming that the new production lines are operational and generating sales.

Navigating Headwinds in Agriculture

While FSI builds its future in the food sector, its legacy agricultural business faced a challenging 2025, which tempered overall revenue growth. The CEO’s comment about a “difficult” year in agriculture reflects a wider industry reality. Throughout 2025, farmers in the U.S. and abroad contended with a tough economic climate where crop prices failed to keep pace with inflation. High input costs for fertilizer and fuel, combined with uncertainty from international tariff changes, squeezed grower margins.

This environment directly impacts demand for FSI's agricultural products, which include chemistry designed to improve crop nutrient availability and reduce fertilizer crystallization. When farmers face financial pressure, spending on such enhancement products can be deferred, impacting sales for suppliers like Flexible Solutions. The difficulties in this segment underscore the strategic importance of the company's diversification. By expanding into the non-cyclical and high-growth food ingredients market, FSI is actively mitigating its exposure to the volatility of the agricultural sector.

Investor Outlook: A Tale of Two Timelines

For investors and market analysts, Flexible Solutions International presents a fascinating case of contrasting short-term performance and long-term potential. The stock has seen a recent downturn, trading below its 200-day moving average and showing negative short-term technical indicators. However, this recent performance stands in stark contrast to a decidedly bullish outlook from financial analysts.

The consensus rating for FSI stock remains a "Buy," with one analyst maintaining a target price of $11.50 per share. The underlying optimism is fueled by staggering growth forecasts for 2026. Earnings are projected to grow by over 80% annually, with earnings per share (EPS) forecast to jump from an estimated $0.16 in 2025 to $0.56 in 2026. Perhaps most tellingly, sales are projected to surge by over 64% in 2026 to reach approximately $67.4 million, driven almost entirely by the new food-grade contracts coming fully online.

Investors are now keenly awaiting the complete audited financial results, which will be filed with the SEC after the market closes on March 31, 2026. These documents will provide the first comprehensive look at the company's profitability, cash flow, and balance sheet following its year of transition. The subsequent conference call scheduled for the morning of April 1, 2026, will be a critical event, as investors and analysts will seek confirmation and detailed guidance on the revenue ramp-up that is expected to define the company's breakout year.